We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Rackspace Technology
RXT
$967M
| $182K | ﹤0.01% |
44,600
-7,900
| -15% | -$45.8K |
|
2227
VirnetX Holding Corp
VHC
$54.4M
| $182K | ﹤0.01% |
7,766
+3,705
| +91% | +$119K |
|
|
HIMX
2228
Himax Technologies
HIMX
$2.09B
| $180K | ﹤0.01% |
+37,200
| New | +$237K |
|
2229
SI-BONE Inc
SIBN
$795M
| $178K | ﹤0.01% |
10,200
-7,200
| -41% | -$115K |
|
2230
Cato Corp
CATO
$67.3M
| $176K | ﹤0.01% |
18,400
+4,600
| +33% | +$52K |
|
2231
Archer Aviation
ACHR
$3.68B
| $175K | ﹤0.01% |
67,000
+600
| +0.9% | +$2.11K |
|
|
DMRA
2232
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.81B
| $174K | ﹤0.01% |
3,680
-516
| -12% | -$26.2K |
|
2233
Amplitude
AMPL
$1.16B
| $172K | ﹤0.01% |
+11,100
| New | +$178K |
|
2234
Orion Group Holdings
ORN
$485M
| $170K | ﹤0.01% |
64,500
-2,800
| -4% | -$7.35K |
|
2235
Taysha Gene Therapies
TSHA
$1.57B
| $169K | ﹤0.01% |
87,700
-18,100
| -17% | -$65.7K |
|
|
TCON
2236
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $168K | ﹤0.01% |
5,035
-2,990
| -37% | -$114K |
|
2237
Forte Biosciences
FBRX
$1.57B
| $167K | ﹤0.01% |
6,258
-662
| -10% | -$21K |
|
|
FONR
2238
DELISTED
Fonar
FONR
| $167K | ﹤0.01% |
11,800
-6,200
| -34% | -$90.6K |
|
|
IVAC
2239
DELISTED
Intevac Inc
IVAC
| $166K | ﹤0.01% |
35,700
-47,500
| -57% | -$230K |
|
|
BORR
2240
Borr Drilling
BORR
$1.2B
| $165K | ﹤0.01% |
49,750
+8,856
| +22% | +$32.9K |
|
2241
Definitive Healthcare
DH
$74.6M
| $163K | ﹤0.01% |
10,500
-200
| -2% | -$4.4K |
|
2242
Annovis Bio
ANVS
$71.9M
| $162K | ﹤0.01% |
11,800
-6,200
| -34% | -$81.5K |
|
2243
China Yuchai International
CYD
$1.74B
| $162K | ﹤0.01% |
22,190
-4,500
| -17% | -$37.7K |
|
2244
iQIYI
IQ
$1.21B
| $162K | ﹤0.01% |
59,600
-42,200
| -41% | -$156K |
|
2245
Manulife Financial
MFC
$74.2B
| $160K | ﹤0.01% |
10,200
-150,200
| -94% | -$2.63M |
|
|
HTT
2246
High Templar Tech Ltd
HTT
$377M
| $160K | ﹤0.01% |
177,400
+6,100
| +4% | +$6.54K |
|
2247
StealthGas
GASS
$329M
| $159K | ﹤0.01% |
+62,200
| New | +$171K |
|
2248
Westwood Holdings Group
WHG
$187M
| $157K | ﹤0.01% |
16,300
| – | – |
|
|
CRON
2249
Cronos Group
CRON
$1.06B
| $155K | ﹤0.01% |
+54,900
| New | +$169K |
|
2250
Imunon
IMNN
$6.43M
| $155K | ﹤0.01% |
7,054
-1,709
| -20% | -$48K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.